These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18157525)

  • 1. Induction of CYP1A2 by heavy coffee consumption in Serbs and Swedes.
    Djordjevic N; Ghotbi R; Bertilsson L; Jankovic S; Aklillu E
    Eur J Clin Pharmacol; 2008 Apr; 64(4):381-5. PubMed ID: 18157525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparisons of CYP1A2 genetic polymorphisms, enzyme activity and the genotype-phenotype relationship in Swedes and Koreans.
    Ghotbi R; Christensen M; Roh HK; Ingelman-Sundberg M; Aklillu E; Bertilsson L
    Eur J Clin Pharmacol; 2007 Jun; 63(6):537-46. PubMed ID: 17370067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of CYP1A2 by heavy coffee consumption is associated with the CYP1A2 -163C>A polymorphism.
    Djordjevic N; Ghotbi R; Jankovic S; Aklillu E
    Eur J Clin Pharmacol; 2010 Jul; 66(7):697-703. PubMed ID: 20390257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of genetic polymorphisms, smoking, gender and age on CYP1A2 activity in a Turkish population.
    Gunes A; Ozbey G; Vural EH; Uluoglu C; Scordo MG; Zengil H; Dahl ML
    Pharmacogenomics; 2009 May; 10(5):769-78. PubMed ID: 19450128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels.
    Landi MT; Zocchetti C; Bernucci I; Kadlubar FF; Tannenbaum S; Skipper P; Bartsch H; Malaveille C; Shields P; Caporaso NE; Vineis P
    Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):693-8. PubMed ID: 8877060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of caffeine as an in vivo probe for CYP1A2 using measurements in plasma, saliva, and urine.
    Carrillo JA; Christensen M; Ramos SI; Alm C; Dahl ML; Benitez J; Bertilsson L
    Ther Drug Monit; 2000 Aug; 22(4):409-17. PubMed ID: 10942180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of environmental and genetic factors on CYP2D6, CYP1A2 and UDP-glucuronosyltransferases in man using sparteine, caffeine, and paracetamol as probes.
    Bock KW; Schrenk D; Forster A; Griese EU; Mörike K; Brockmeier D; Eichelbaum M
    Pharmacogenetics; 1994 Aug; 4(4):209-18. PubMed ID: 7987405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between assessment of cytochrome P450 1A2 activity and enzyme activity scores, and their relation to clozapine exposure.
    Alarcan H; Cannet P; Camus V; Fond G; Zendjidjian X; Guilhaumou R; Quaranta S
    Br J Clin Pharmacol; 2023 May; 89(5):1665-1671. PubMed ID: 36507652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms of CYP1A2 and CYP2A6 activity: phenotypes and the effect of age and sex in a Nigerian population.
    Adehin A; Bolaji OO
    Drug Metab Pers Ther; 2015 Sep; 30(3):203-10. PubMed ID: 26098700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYP1A2 polymorphisms, occupational and environmental exposures and risk of bladder cancer.
    Pavanello S; Mastrangelo G; Placidi D; Campagna M; Pulliero A; Carta A; Arici C; Porru S
    Eur J Epidemiol; 2010 Jul; 25(7):491-500. PubMed ID: 20559687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma caffeine metabolite ratio (17X/137X) in vivo associated with G-2964A and C734A polymorphisms of human CYP1A2.
    Han XM; Ou-Yang DS; Lu PX; Jiang CH; Shu Y; Chen XP; Tan ZR; Zhou HH
    Pharmacogenetics; 2001 Jul; 11(5):429-35. PubMed ID: 11470995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of smoking, smoking cessation, and genetic polymorphisms on CYP1A2 activity and inducibility.
    Dobrinas M; Cornuz J; Oneda B; Kohler Serra M; Puhl M; Eap CB
    Clin Pharmacol Ther; 2011 Jul; 90(1):117-25. PubMed ID: 21593735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of coffee consumption and CYP1A2 polymorphism with risk of impaired fasting glucose in hypertensive patients.
    Palatini P; Benetti E; Mos L; Garavelli G; Mazzer A; Cozzio S; Fania C; Casiglia E
    Eur J Epidemiol; 2015 Mar; 30(3):209-17. PubMed ID: 25595320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of the urine flow rate on some caffeine metabolite ratios used to assess CYP1A2 activity.
    Sinués B; Fanlo A; Bernal ML; Mayayo E; Soriano MA; Martínez-Ballarin E
    Ther Drug Monit; 2002 Dec; 24(6):715-21. PubMed ID: 12451287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five caffeine metabolite ratios to measure tobacco-induced CYP1A2 activity and their relationships with urinary mutagenicity and urine flow.
    Sinués B; Sáenz MA; Lanuza J; Bernal ML; Fanlo A; Juste JL; Mayayo E
    Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):159-66. PubMed ID: 10067814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of drug clearance in a smoking population: modeling the impact of variable cigarette consumption on the induction of CYP1A2.
    Plowchalk DR; Rowland Yeo K
    Eur J Clin Pharmacol; 2012 Jun; 68(6):951-60. PubMed ID: 22258279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) intoxication: insights into the measurement of hepatic cytochrome P450 1A2 induction.
    Abraham K; Geusau A; Tosun Y; Helge H; Bauer S; Brockmöller J
    Clin Pharmacol Ther; 2002 Aug; 72(2):163-74. PubMed ID: 12189363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caffeine N3-demethylation (CYP1A2) in a population with an increased exposure to polychlorinated biphenyls.
    Petersen MS; Halling J; Damkier P; Nielsen F; Grandjean P; Weihe P; Brøsen K
    Eur J Clin Pharmacol; 2006 Dec; 62(12):1041-8. PubMed ID: 17089110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A distribution study of CYP1A2 phenotypes among smokers and non-smokers in a cohort of healthy Caucasian volunteers.
    Schrenk D; Brockmeier D; Mörike K; Bock KW; Eichelbaum M
    Eur J Clin Pharmacol; 1998 Jan; 53(5):361-7. PubMed ID: 9516038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human cytochrome P4501A2.
    Landi MT; Sinha R; Lang NP; Kadlubar FF
    IARC Sci Publ; 1999; (148):173-95. PubMed ID: 10493258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.